Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/7/04 → 4/30/08 |
Funding
- Fujisawa Pharmaceuticals: $18,410.00
Phase 3 Randomized Double-Blinded Comparative Study of Micafungin (FK463) Versus Caspofungin as Antifungal Treatment in Patients with Invasive Candidiasis or Candidemia
- Greenberg, Richard (PI)